Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

Presentation TCT 2025

TCT 538: Real-World Outcomes Following Cardiac Contractility Modulation in HFrEF: A Single-Center Retrospective Experience

Presenter: Kareem Elgendi

October 27, 2025

News Conference News HFSA 2025

CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF

Yael L. Maxwell

September 29, 2025

Presentation THT 2025

Real-World Survival Comparison of Symptomatic Patients With Heart Failure Treated With Cardiac Contractility Modulation (CCM) vs. Cardiac Resynchronization Therapy (CRT)

Presenter: Andrew Sauer

February 13, 2025

Presentation THT 2025

Cardiac Contractility Modulation Across the Spectrum of EFs

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 12, 2025

Presentation THT Abstracts 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 11, 2025

News Daily News

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Todd Neale

January 23, 2025

Presentation THT 2024

Cardiac Contractility Modulation

Presenter: Kanika P. Mody

March 05, 2024

Presentation THT 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presenter: Daniel Asemota

March 05, 2024

Presentation THT 2023

Cardiac Contractility Modulation for HFrEF and HFpEF: Impulse Dynamics

Presenter: Javed Butler

March 21, 2023

Presentation TCT 2022

TCT 344: UTILIZING CARDIAC CONTRACTILITY MODULATION THERAPY FIRST IN PATIENTS WITH LOW EF 25-35% IMPROVES LV FUNCTION AND HEART FAILURE STATUS WITHOUT THE NEED FOR CONCOMITATNT IMPLANTABLE DEFIBRILLATOR: EARLY US URBAN EXPERIENCE IN AN ACADEMIC TERTIARY…

Presenter: Majd Hemam

September 18, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

Presentation THT 2022

Question & Answers

Presenter: Vinay Thohan

February 02, 2022

Presentation THT 2022

The Clinical Story of CCM® – Looking ahead to HFpEF Population

Presenter: Javed Butler

February 02, 2022

Presentation THT 2022

Adopting CCM® Therapy into Practice – Sharing the European Experience

Presenter: Jurgen Kuschyk

February 02, 2022

Presentation THT 2022

Understanding the MoA of Cardiac Contractility Modulation

Presenter: Kanika Mody

February 02, 2022

Presentation THT 2022

Welcome and Introduction

Presenter: Vinay Thohan

February 02, 2022

Presentation TCT 2019

Cardiac Contractility Modulation (CCM)

Presenter: Daniel Burkhoff

September 28, 2019

News Daily News

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

Yael L. Maxwell

March 22, 2019

News Daily News

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

Yael L. Maxwell

December 05, 2018

Advertisement

TCT 538: Real-World Outcomes Following Cardiac Contractility Modulation in HFrEF: A Single-Center Retrospective Experience

CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF

Real-World Survival Comparison of Symptomatic Patients With Heart Failure Treated With Cardiac Contractility Modulation (CCM) vs. Cardiac Resynchronization Therapy (CRT)

Cardiac Contractility Modulation Across the Spectrum of EFs

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Cardiac Contractility Modulation

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Cardiac Contractility Modulation for HFrEF and HFpEF: Impulse Dynamics

TCT 344: UTILIZING CARDIAC CONTRACTILITY MODULATION THERAPY FIRST IN PATIENTS WITH LOW EF 25-35% IMPROVES LV FUNCTION AND HEART FAILURE STATUS WITHOUT THE NEED FOR CONCOMITATNT IMPLANTABLE DEFIBRILLATOR: EARLY US URBAN EXPERIENCE IN AN ACADEMIC TERTIARY…

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Question & Answers

The Clinical Story of CCM® – Looking ahead to HFpEF Population

Adopting CCM® Therapy into Practice – Sharing the European Experience

Understanding the MoA of Cardiac Contractility Modulation

Welcome and Introduction

Cardiac Contractility Modulation (CCM)

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content